Showing results (2511-2520 of 3,353) with videos related to
Sort By:
Pageof 336
Pharmacoeconomics|December 15, 2010
Calibrating models in economic evaluation: a seven-step approachTazio Vanni, Jonathan Karnon, Jason Madan, et al.Pharmacoeconomics|November 11, 2010
Value of information in the osteoarthritis setting: cost effectiveness of COX-2 selective inhibitors, traditional NSAIDs and proton pump inhibitorsNicholas Latimer, Joanne Lord, Robert L Grant, et al.Pharmacoeconomics|June 16, 2010
Frequency of treatment-effect modification affecting indirect comparisons: a systematic reviewMichael Coory, Susan JordanPharmacoeconomics|July 13, 2010
Fondaparinux: a pharmacoeconomic review of its use in the management of non-ST-segment elevation acute coronary syndromeKate McKeage, Katherine A Lyseng-WilliamsonPharmacoeconomics|May 15, 2010
Methodological concerns with economic evaluations of meningococcal vaccinesTeresa L KaufPharmacoeconomics|September 14, 2010
Comparative effectiveness research: the view from a pharmaceutical companyMarc L Berger, David GraingerPharmacoeconomics|June 17, 2010
Cost effectiveness of leukotriene receptor antagonists versus inhaled corticosteroids for initial asthma controller therapy: a pragmatic trialEdward C F Wilson, Erika J Sims, Stanley D Musgrave, et al.Pharmacoeconomics|August 31, 2010
A new method for examining the cost savings of reducing COPD exacerbationsDouglas W Mapel, Michael Schum, Eva Lydick, et al.Pharmacoeconomics|January 31, 2009
The applicability and generalizability of findings from clinical trials for health-policy decisionsNick Freemantle, Franz HesselPharmacoeconomics|January 31, 2009
Comparing the cost effectiveness of risperidone and olanzapine in the treatment of schizophrenia using the net-benefit regression approachAnnemieke De Ridder, Diana De GraevePageof 336